Airfinity Ltd

Airfinity was invited to give an exclusive briefing at The White House on the rising threat of infectious disease outbreaks. Speaking to Dr. Paul Friedrichs and members of the Office for Pandemic Preparedness and Response Policy and the National Security Council, The White House, CEO Rasmus Bech Hansen and VP of Biorisk Michelle Holko presented our latest analysis on the most imminent threats to the United States, including the detection of avian #influenza in US mammalian livestock, the impact of reduced #vaccine uptake on #measles cases, and #mpox clade IIb and clade I outbreaks. Airfinity uses AI-augmented simulations and forecasts to enable better risk assessment and earlier warning systems that support health, security, and defense goals for multiple G7 governments. To organise a briefing for your team, email us directly at contact@airfinity.com. 

A new more severe #mpox strain is spreading rapidly in the DRC, with concerns about the speed at which it might reach other countries. This new strain, mpox clade Ib, is believed to spread through non-sexual contact, making it more dangerous and transmissible than previous illnesses. With the #Euros2024 well underway, and the upcoming #ParisOlympics there are concerns of increased spread through the high volume of international travellers and large crowds. Our analysis shows Spanish football fans are most likely to spread mpox (clade IIb) during the euros. Reach out to infectiousdiseases@airfinity.com to learn more about mpox risk at these global events.

Has the #pandemic somehow fundamentally changed us or the pathogens which surround us? That’s the question which has been sparked by Airfinity’s recent analysis on the scale of disease outbreaking resurging around the world. Our study shows over 40 countries or territories have reported at least one #infectious #disease resurgence that’s 10-fold or more over their pre-pandemic baseline. The Telegraph examine whether poverty and international conflict could be behind the outbreaks as well as vaccinations, immunity debt and climate change. Read the article below or visit our website to find out more. https://lnkd.in/ekTSnTSQ

Is avian influenza becoming less deadly and does it mean less risk? New analysis shows that case fatality rate (CFR) has dropped to a 33% average over the last 9 years, from 62% pre-2015. While this may appear to be a positive development, a lower CFR typically signifies a better adapted #virus to a host. If this trend continues, it may signal #H5N1 becoming more suited for sustaining human-human infection. To learn more about the pandemic potential of H5N1, please get in touch via infectiousdiseases@airfinity.com

More than 40 countries or territories have reported at least one #infectiousdisease resurgence that’s 10-fold or more over their pre-pandemic baseline. Airfinity and Bloomberg News have collaborated to analyse the global #data on #disease outbreaks, to better understand the scale of the issue and what's really driving it. We have identified three main factors contributing to these resurgences: falling #vaccination rates, overall decline in population #immunity and #climatechange. To see the full analysis, and explore our new interactive spike map showing the largest outbreaks across the globe, read the below article or visit our website here: https://lnkd.in/eMb8bjvK

Today, Airfinity CEO and founder, Rasmus Bech Hansen, presented at Flagship Pioneering’s London event, Reimagining Immunisation: The future of 21st century vaccines. He joined a panel of other scientific leaders, regulators and policy makers including CEO of CEPI (Coalition for Epidemic Preparedness Innovations), Richard Hatchett, former CEO of Gavi, the Vaccine Alliance, Seth Berkley and Lovisa Afzelius, Origination Partner at Flagship Pioneering. The discussion delved into the challenges of #pandemic readiness, #vaccine innovation and the need for #global surveillance and data-sharing mechanisms for vaccine development.

Working within an ecosystem of innovation, our researchers are inspired to deliver leading-edge science for patients. Thanks to all who are dedicated to the strength and longevity of R&D for driving progress in cancer care. Check out this new report from Airfinity: https://msd.gl/3KvvOJP #MSDsponsored

New analysis by Airfinity shows there has been a 300% rise in approved new #cancer treatments in the last two decades, with the US Cancer Moonshot Goal achievable by 2048. The findings come from the newly released 'Advancements in Oncology: A 20-Year Study of Breakthroughs, Treatments, and Outcomes', a report commissioned by MSD that takes an in-depth look at global cancer disease burden and drug approval trends over the past two decades. Click below to access the full findings of the analysis, including approval trends by both cancer type and product group, as well as Airfinity's forecasted rates of US cancer mortality rates. #ASCO2024 #drugdevelopment #oncology FDA European Medicines Agency American Society of Clinical Oncology (ASCO)

A new pandemic is among the biggest risks facing the West, argues our CEO Rasmus Bech Hansen in this article in the Telegraph. “Although the West is today much better prepared than before Covid, there is still much to be done. The Pandemic Agreement, if it can be agreed upon, is part of the solution but it won’t be enough. Western allies need to develop a joint pandemic strategy and anchor it clearly in an international institution", he writes. In the article, he outlines key findings from Airfinity’s analysis that shows democracies had fewer excess deaths than autocracies during the pandemic (first presented at the Copenhagen Democracy Summit). https://lnkd.in/ebjqxfrX